CLEAR CELL RCC
Clinical trials for CLEAR CELL RCC explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RCC trials appear
Sign up with your email to follow new studies for CLEAR CELL RCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enzelkitug enters first human trials
Disease control Recruiting nowThis early-phase trial is testing a new drug called enzelkitug, alone or with standard immunotherapies, in people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. A…
Matched conditions: CLEAR CELL RCC
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug cocktail shows promise in shrinking kidney tumors before surgery
Disease control Recruiting nowThis phase 2 trial is testing whether giving two drugs—toripalimab and lenvatinib—before and after surgery can improve outcomes for people with clear cell renal cell carcinoma. The study enrolls 75 patients with different stages of kidney cancer. Participants receive the drugs fo…
Matched conditions: CLEAR CELL RCC
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC